Transcript ID | Brain | Heart | Kidney | Liver | Muscle |
---|---|---|---|---|---|
ENSDART00000102827 | 1.030±0.26 | 2.520±0.16 | 1.699±0.66 | 0.255±0.00 | 1.412±0.00 |
Transcript Info |
||||||
Description: | leucine proline-enriched proteoglycan (leprecan) 1 | |||||
---|---|---|---|---|---|---|
Transcript Accession | Transcript Name | Contained in Gene | Tax ID | Strand | Position | Biotype |
ENSDART00000102827 | lepre1-001 | ENSDARG00000071212 | 7955 | - | 11:40309260-40338900 | protein_coding |
Expression Patterns
|
Conserved Regions | |||
---|---|---|---|
Region ID | Sub-Region | Region Type | Position |
CIL_0005B1 | CIL_0005B1_0001 | CGP | 11:40247410-40338900 |
CIL_0005B2 | CIL_0005B2_0001 | CGP | 11:40309260-40345902 |
Gene Ontology | ||
---|---|---|
GO ID | Evidence Type | GO Description |
GO:0005506 | IEA | iron ion binding |
GO:0016491 | IEA | oxidoreductase activity |
GO:0016705 | IEA | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0016706 | IEA | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors |
GO:0031418 | IEA | L-ascorbic acid binding |
GO:0055114 | IEA | oxidation-reduction process |
Homologs | |||||
No Homologs available. |
---|